Loading company…
Wision AI makes AI-aided oncology diagnostic tools, including the EndoScreener for gastrointestinal endoscopy.
Founded in 2016 in Shanghai, China, Wision AI, Ltd. develops digital health solutions with a focus on oncology diagnostics. Its products include the EndoScreener, an AI-aided tool for gastrointestinal endoscopy, and PathoCruz 3D, which localizes cancerous regions in whole slide imaging. The EndoScreener holds CE-MDR Mark and FDA 510K approvals, and products are sold to hospitals and diagnostic centers. Liu Jingjia is CEO, and the company is at Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in